Author

Myroslava Doronina

Observed names: M. Doronina, M.V. Doronina, Myroslava V. Doronina

Institutions: Shupyk National Healthcare University of Ukraine, Kyiv Zoological Park of National Importance

Observed institutions: Shupyk National Healthcare University of Ukraine, Kyiv Zoological Park of National Importance

ORCID: 0009-0006-8989-454X

Observed ORCID: 0009-0006-8989-454X

OpenAlex ID: A5117069880

Ip02-40 Preliminary Anti-tumor Activity and Safety Results From Advanced-2: a Phase 2 Open-label Study of Intravesical Tara-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

2025 · Gautam T. Jayram, Eugene Kramolowsky, et al. · The Journal of Urology · 1

Study of Predictive Value of Rad51 Expression for the Effectiveness of Platinum-based Therapy of High-grade Serous Ovarian Carcinoma

2026 · P. Gordiichuk, M. Doronina, et al. · Experimental Oncology

Ip02-04 Advanced-2 (cohort A): Preliminary Efficacy and Safety Data in Bcg-naïve Participants With High-grade Non-muscle Invasive Bladder Cancer

2026 · Mark Tyson, Gautam Jayram, et al. · The Journal of Urology

Interim safety and tolerability of TARA-002 in patients with BCG-naïve and unresponsive high-grade non-muscle invasive bladder cancer in ADVANCED-2.

2026 · Timothy Clinton, Timothy D. Lyon, et al. · Journal of Clinical Oncology

Modern recommendations for the medical treatment of epithelial ovarian tumors

2025 · P.I. Gordiichuk, M.V. Doronina · Reproductive health of woman

Works count: 5

Citation count: 1

H-index: 1

I10-index: